Stated Timothy Wilens.

This study viewed patients who were going for a stable dosage of a long-acting stimulant medicine but who continuing to see ADHD symptoms, stated Timothy Wilens, MD, Personnel in the Pediatric Psychopharmacology Unit at Massachusetts General Medical center and Associate Professor of Psychiatry at Harvard Medical College, who led the scholarly study. INTUNIV is definitely a selective alpha-2A agonist authorized for the treatment of ADHD in kids and adolescents ages 6 to 17 .